cpalacio2021-01-27T10:27:15-05:00 Dissecting the CMS Best Price Rule: What it Means for Manufacturer Co-Pay Programs
cpalacio2021-01-21T15:53:20-05:00 The Evidence is In: Integrated Hub and Co-Pay Services Really Do Yield Better Results
cpalacio2021-02-08T12:26:49-05:00 Using Digital Engagement to Solve Pain Points Along the Patient Journey
cpalacio2021-01-19T04:45:07-05:00 Understanding Implications of Proposed Best Price Revisions for Manufacturer Assistance Programs
Kevin Brasco2021-01-16T14:05:24-05:00 Detecting Pharmacy Fraud: Is Your Brand’s Co-Pay Program Protected?
Kevin Brasco2021-01-16T14:06:05-05:00 Co-Pay Accumulator Programs: New Battle or Just Another Front in a Never-Ending War?
Kevin Brasco2021-02-08T12:18:43-05:00 Accumulator Adjustment Programs: What They Are, What They Are Not, and How Should an Affected Health Plan Member Respond?
Kevin Brasco2021-01-16T14:06:35-05:00 Co-Pay Accumulators: Measuring the Impact on Patients and Pharmaceutical Manufacturers
Kevin Brasco2021-01-16T14:06:45-05:00 Examining the Financial Implications of Co-Pay Accumulator Plans
Kevin Brasco2021-01-16T14:09:32-05:00 Integrating Engagement and Adherence Solutions with Affordability Programs
Kevin Brasco2021-01-16T14:09:41-05:00 The Benefits of Integrating Adherence and Engagement Into Co-Pay and Hub Programs
Kevin Brasco2021-01-16T14:10:50-05:00 Leveraging Virtual Engagement to Further HCP Access and Drive Brand Reach
Kevin Brasco2021-01-16T14:11:12-05:00 The New Sales Model: Virtual Engagement in the Time of COVID-19
TC Resources2021-01-16T14:11:51-05:00 The Rise of Co-Pay Accumulator Programs: Are Your Brand’s Patients at Risk?
